Recruiting studies: Bone Marrow Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Phase N/A · 6 location(s) · Medical College of Wisconsin · NCT07227155 AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966 Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intol
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06802055 A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07586735 Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05012111 CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
NA · 5 location(s) · BioCardia, Inc. · NCT06258447 Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilic
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03173937 Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06744283 Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974 CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06633328 Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07628972 Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Phase 1/Phase 2 · 2 location(s) · Paul Szabolcs · NCT03500731 The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
NA · 1 location(s) · Nationwide Children's Hospital · NCT07718204 Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes
Phase N/A · 1 location(s) · Sohag University · NCT05436587 Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Phase N/A · 1 location(s) · Northwell Health · NCT07186179 Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Phase 1/Phase 2 · 4 location(s) · Washington University School of Medicine · NCT03128996 HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Phase 2 · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02143830 Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Pati
Phase N/A · 1 location(s) · Mayo Clinic · NCT06752577 Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT02356653 Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · 3 location(s) · Mayo Clinic · NCT02958462 High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523 Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Phase 2 · 3 location(s) · Children's Hospital of Philadelphia · NCT05194397 Nucleoside Therapy in Patients With Telomere Biology Disorders
Phase 1 · 1 location(s) · Suneet Agarwal · NCT06817590 Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06695741 A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combine
Phase 2 · 2 location(s) · Franziska Wachter · NCT05796570 Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875 Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07714512 Second STOP After Pioglitazone Priming in CML Patients
Phase 2 · 6 location(s) · Versailles Hospital · NCT02889003 Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells a
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03520647

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.